Vactech

Develops vaccines and diagnostics for type 1 diabetes, celiac disease and enterovirus diseases, and licenses its patents

Tampere, FinlandFounded 2001vactech.fiWebsite technologies

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-10-28

About Vactech

Vactech Oy is a Finnish biotechnology company developing vaccines and diagnostics for type 1 diabetes, celiac disease and enterovirus-related conditions. Its flagship product is PRV-101, a patented preventive vaccine for type 1 diabetes that is in clinical trials. Its IMAVAC platform uses virus-like particles for vaccine development.

The company develops and licenses vaccines and technologies for vaccines and diagnostics. It holds patents covering the preventive type 1 diabetes vaccine, antiviral drugs and diagnostic assays for type 1 diabetes, and international patents on virus-based products for celiac disease. It collaborates with academic groups and industry partners, and has taken part in two EU-funded research consortia, PEVNET and ENT1DEP.

Vactech was founded in 2001 and is headquartered in Tampere, Finland. In November 2025 it opened a Research Hub at Tampere University's Kauppi campus.

Product: PRV-101, a patented preventive vaccine for type 1 diabetes in clinical trials; IMAVAC virus-like particle vaccine technology; enterovirus diagnostics.

Jobs at Vactech

No open positions listed right now.

Leadership

More biotech & pharma companies

  • 3PBIOVIAN

    Biologics CDMO providing protein, viral vector, plasmid DNA and cell therapy manufacturing for biotech and pharma companies
    Noáin, FinlandBiotech & pharmaFounded 20031 open job
    New on Evolc
  • Aastat

    Biostatistics and statistical programming services for pharmaceutical clients, delivered on a functional service provision model
    Turku, FinlandBiotech & pharmaFounded 2025
    Young companyNew on Evolc
  • Afekta Technologies

    Metabolomics analysis of microbial and plant compounds for food manufacturers and academic researchers
    Kuopio, FinlandBiotech & pharmaFounded 2017
    New on Evolc
  • Amitav

    Research-grade chemicals and custom synthesis for academic, pharma and biotech labs, with global shipping
    Helsinki, FinlandBiotech & pharmaFounded 2018
    New on Evolc
  • Aplagon

    Develops therapies for patients with thromboinflammatory cardiovascular diseases
    Helsinki, FinlandBiotech & pharmaFounded 2009
    New on Evolc
  • Aq Biotech

    Develops phage-based biosensor diagnostics for early disease detection and monitoring from non-invasive biological samples
    Turku, FinlandBiotech & pharmaFounded 20251 open job
    Young companyNew on Evolc

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Cookiebot
  • Google Analytics 4
  • LiteSpeed
  • WordPress
  • jQuery